Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria

References

• Zoja C, Abbate M, Remuzzi G. Progression of chronic kidney disease: insights from animal models. Curr Opin Nephrol Hypertens 2006;15:250–7.
   PubMed Web of Science ®Google Scholar
• Palmer BF. Proteinuria as a therapeutic target in patients with chronic kidney disease. Am J Nephrol 2007;27:287–93.
   PubMed Web of Science ®Google Scholar
• Viedt C, Orth SR. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 2002;17:2043–7.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Leonard EJ. Human monocyte chemoattractant protein-1: structure and function (review). Cytokines. 1992;4:131–52.
   PubMedGoogle Scholar
• Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 2000;58:684–90.
   PubMed Web of Science ®Google Scholar
• Prodjosudjadi W, Gerritsma JS, van Es LA, Daha MR, Bruijn JA. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995;44:148–55.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 1996;27:640–6.
   PubMed Web of Science ®Google Scholar
• Cockwell P, Howie AJ, Adu D, Savage CO. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int 1998;54:827–36.
   PubMed Web of Science ®Google Scholar
• Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 2000;57:147–58.
   PubMed Web of Science ®Google Scholar
• Wang Y, Rangan GK, Tay YC, Wang Y, Harris DC. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 1999;10:1204–13.
   PubMed Web of Science ®Google Scholar
• Qi W, Chen X, Polhill TS, Sumual S, Twigg S, Gilbert RE, TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol 2006;290:F703–9.
   PubMed Web of Science ®Google Scholar
• Wang SN, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol Renal Physiol 2000;278:F554–60.
   PubMed Web of Science ®Google Scholar
• Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Urinary levels of epidermal growth factor. Interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton) 2009;14:613–20.
   PubMed Web of Science ®Google Scholar
• Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000;58:1492–9.
   PubMed Web of Science ®Google Scholar
• Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004;19:2505–12.
   PubMed Web of Science ®Google Scholar
• Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diabetes Complications 2003;17:11–5.
   PubMed Web of Science ®Google Scholar
• Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362:629–39.
   PubMed Web of Science ®Google Scholar
• Souto MF, Teixeira AL, Russo RC, Penido MG, Silveira KD, Teixeira MM, Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria. Pediatr Res 2008;64:637–42.
   PubMed Web of Science ®Google Scholar
• Schlöndorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int 1997;51:610–21.
   PubMed Web of Science ®Google Scholar
• Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995;73:804–9.
   PubMed Web of Science ®Google Scholar
• Jin KB, Choi HJ, Kim HT, Hwang EA, Han SY, Park SB, Cytokine array after cyclosporine treatment in rats. Transplant Proc 2008;40:2682–4.
   PubMed Web of Science ®Google Scholar
• Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007;71:1205–14.
   PubMed Web of Science ®Google Scholar
• Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008;172:299–308.
   PubMed Web of Science ®Google Scholar
• Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006;69:2131–47.
   PubMed Web of Science ®Google Scholar
• Huang Z, Wen Q, Zhou SF, Yu XQ. Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome. Cytokine 2008;42:222–33.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S, Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 2003;14:1496–505.
   PubMed Web of Science ®Google Scholar
• Remuzzi G. A unifying hypothesis for renal scarring linking protein trafficking to the different mediators of injury. Nephrol Dial Transplant 2000;15(Suppl 6):58–60.
   PubMedGoogle Scholar
• Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. Ren Fail 2003;25:439–44.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Yoshiumura T, Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 1992;148:2148–53.
   PubMed Web of Science ®Google Scholar
• Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994;71:536–42.
   PubMed Web of Science ®Google Scholar
• Ou ZL, Hotta O, Natori Y, Sugai H, Taguma Y, Natori Y. Enhanced expression of C chemokine lymphotactin in IgA nephropathy. Nephron 2002;91:262–9.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, Urinary levels of chemokines (MCAF/MCP-1. IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukoc Biol 1998;63:493–9.
   PubMed Web of Science ®Google Scholar
• Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra F, Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 1996;7:906–13.
   PubMed Web of Science ®Google Scholar
• Sun Y, Yuan S, Xu X. Expression of MCP-1 in renal tissues of patients with IgA nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:1023–8.
   PubMedGoogle Scholar
• Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005;68:437–55.
   PubMed Web of Science ®Google Scholar
• Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 2002;22:914–20.
   PubMed Web of Science ®Google Scholar
• Viedt C, Dechend R, Fei J, Hänsch GM, Kreuzer J, Orth SR. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors. nuclear factor-kappaB and activating protein-1. J Am Soc Nephrol 2002;13:1534–47.
   PubMed Web of Science ®Google Scholar
• Suda T, Osajima A, Tamura M, Kato H, Iwamoto M, Ota T, Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase. Kidney Int 2001;60:1705–15.
   PubMed Web of Science ®Google Scholar
• Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 2000;36:1226–41.
   PubMed Web of Science ®Google Scholar
• Hilgers KF, Hartner A, Porst M, Mai M, Wittmann M, Hugo C, Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 2000;58:2408–19.
   PubMed Web of Science ®Google Scholar
• Wada T, Yokoyama H, Su SB, Mukaida N, Iwano M, Dohi K, Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996;49:761–7.
   PubMed Web of Science ®Google Scholar
• Stephan M, Conrad S, Eggert T, Heuer R, Fernandez S, Huland H. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. J Urol 2002;167:1497–502.
   PubMed Web of Science ®Google Scholar
• Wang QY, Chen FQ. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;83:215–9.
   PubMed Web of Science ®Google Scholar
• Alzawawy A, Zohary M, Ablordiny M, and Eldalie M. Estimation of monocyte-chemoattractant protein-1 (MCP-1) level in patients with lupus nephritis. Int J Rheum Dis 2009;12:311–8.
   PubMed Web of Science ®Google Scholar